Search Results
Slidesets
Second generation INSTI regimens for drug naive patients: State of the Art - Daniel Kuritzkes, MD
Presented at:
European HIV Clinical Forum 2019
Slidesets
Seminal HIV-1 RNA and drug concentrations in DTG+3TC dual therapy (ANRS167 Lamidol)- Charlotte Charpentier
Presented at:
European Meeting on HIV & Hepatitis 2019
Abstracts
Dolutegravir- versus low-dose Efavirenz-based regimen for the initial treatment of HIV-1 infection in Cameroon: 96-week results of the ANRS 12313 – NAMSAL trial
C. Kouanfack
Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Slidesets
Case based debate: Is HCC increased with DAA therapy? Con stance- Nicolás Merchante, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Abstracts
High Prevalence of Hepatic Steatosis in Children with Perinatally Acquired HIV Starting Antiretroviral Therapy Beyond Infancy
P. Rose
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Pooled Analysis of 4 International Trials of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Adults Aged >65 or Older Demonstrating Safety and Efficacy: Week 48 Results
Presented at:
International Workshop on HIV & Aging 2020
Abstracts
Human Mobility Patterns Generate Geographically Structured Sub-epidemics in Namibia
Presented at:
International Workshop on HIV Transmission 2019
Slidesets
PI based mono and dual-therapy- Bonaventura Clotet, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2017
Slidesets
Oral Abstract Presentation #5 | Basma Abdi
Presented at:
European Meeting on HIV & Hepatitis 2024